Viyash Scientific Limited (NSE:VIYASH)
India · Delayed Price · Currency is INR 260.35
+1.25 (0.48%)
Sep 3, 2026, 3:15 PM IST
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 113.11 billion as of September 2, 2026. Its market cap has increased by 163.28% in one year.
Market Cap
113.11B
Enterprise Value
117.45B
Revenue
35.75B
Ranking
n/a
PE Ratio
53.52
Stock Price
260.35
ChartMarket Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 113.11B, an increase of 32,426.07%. That is a compound annual growth rate of 30.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 113.11B | 24.71% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 182.19B |
| Cohance Lifesciences | 172.12B |
| Alivus Life Sciences | 165.72B |
| Alembic Pharmaceuticals | 164.11B |
| NATCO Pharma | 152.92B |
| Sudeep Pharma | 130.13B |
| Akums Drugs and Pharmaceuticals | 118.29B |
| Strides Pharma Science | 94.48B |